1. Home
  2. TRX vs CVRX Comparison

TRX vs CVRX Comparison

Compare TRX & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TRX Gold Corporation

TRX

TRX Gold Corporation

HOLD

Current Price

$0.86

Market Cap

228.9M

Sector

N/A

ML Signal

HOLD

Logo CVRx Inc.

CVRX

CVRx Inc.

HOLD

Current Price

$8.44

Market Cap

221.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRX
CVRX
Founded
1990
2000
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
228.9M
221.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TRX
CVRX
Price
$0.86
$8.44
Analyst Decision
Strong Buy
Buy
Analyst Count
2
7
Target Price
$1.25
$13.17
AVG Volume (30 Days)
1.4M
202.6K
Earning Date
01-13-2026
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$57,613,000.00
$55,969,000.00
Revenue This Year
$28.16
$11.49
Revenue Next Year
N/A
$16.26
P/E Ratio
$363.98
N/A
Revenue Growth
39.98
18.44
52 Week Low
$0.27
$4.30
52 Week High
$0.89
$18.55

Technical Indicators

Market Signals
Indicator
TRX
CVRX
Relative Strength Index (RSI) 68.56 37.60
Support Level $0.70 $8.23
Resistance Level $0.89 $8.93
Average True Range (ATR) 0.05 0.53
MACD 0.02 -0.12
Stochastic Oscillator 89.31 15.42

Price Performance

Historical Comparison
TRX
CVRX

About TRX TRX Gold Corporation

TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Share on Social Networks: